Veradigm Inc. Files 8-K: Other Event

TL;DR

Veradigm filed an 8-K for an 'Other Event' on 9/29/25 - details TBD.

AI Summary

Veradigm Inc. filed an 8-K on September 29, 2025, reporting an "Other Event." The filing does not contain specific details about the event, its nature, or any associated financial implications. The company was formerly known as Allscripts Healthcare Solutions, Inc.

Why It Matters

This filing indicates a significant event has occurred for Veradigm Inc., but the lack of detail requires further investigation to understand the implications for the company and its stakeholders.

Risk Assessment

Risk Level: medium — The filing is an 8-K for an 'Other Event' without specific details, which creates uncertainty and potential risk until more information is disclosed.

Key Players & Entities

• Veradigm Inc. (company) — Registrant
• Allscripts Healthcare Solutions, Inc. (company) — Former company name
• September 29, 2025 (date) — Date of report
• 3125061200 (phone_number) — Business phone
• 000-32085 (commission_file_number) — SEC file number

FAQ

Key Financial Figures

• $0.01 — ch registered Common Stock, par value $0.01 per share MDRX N/A (OTC Expert Mark
• $44 million — h the Company repurchased approximately $44 million in aggregate principal amount of the Co
• $50 m — or total consideration of approximately $50 million, consisting of an amount of cash
• $1,122.50 — onsisting of an amount of cash equal to $1,122.50 for each $1,000 principal amount of Con
• $1,000 — unt of cash equal to $1,122.50 for each $1,000 principal amount of Convertible Notes r
• $20 thousand — e Repurchase Transaction, approximately $20 thousand in aggregate principal amount of Conver

Filing Documents

• mdrx-20250929.htm (8-K) — 40KB
• 0001193125-25-223210.txt ( ) — 140KB
• mdrx-20250929.xsd (EX-101.SCH) — 23KB
• mdrx-20250929_htm.xml (XML) — 4KB

01 Other Events

Item 8.01 Other Events. Veradigm Inc. (the "Company") entered into a repurchase agreement (the "Repurchase Agreement") with a certain holder of the Company's 0.875% Convertible Senior Notes due 2027 (the "Convertible Notes"), for itself and on behalf of certain beneficial owners, pursuant to which the Company repurchased approximately $44 million in aggregate principal amount of the Convertible Notes for total consideration of approximately $50 million, consisting of an amount of cash equal to $1,122.50 for each $1,000 principal amount of Convertible Notes repurchased, plus accrued and unpaid interest from and including July 1, 2025 to but excluding September 29, 2025, the repurchase date (collectively, the "Repurchase Transaction"). The Repurchase Transaction was negotiated with the holder of the repurchased Convertible Notes and was not made pursuant to a publicly announced repurchase program. Following the Repurchase Transaction, approximately $20 thousand in aggregate principal amount of Convertible Notes remain outstanding under that certain Indenture, dated as of December 9, 2019, as supplemented by that certain First Supplemental Indenture, dated as of February 5, 2024, relating to the Convertible Notes, between the Company and U.S. Bank Trust Company, National Association, as successor in interest to U.S. Bank National Association, as trustee, which contains biannual repurchase rights at the option of the holders of Convertible Notes.

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. VERADIGM INC. Date: September 29, 2025 By: /s/ Leland Westerfield Leland Westerfield Interim Chief Financial Officer

View Full Filing

View this 8-K filing on SEC EDGAR